Works matching DE "CANCER invasiveness"

Results: 5000
    1
    2
    3
    4

    Cystathionine gamma‐lyase‐mediated hypoxia inducible factor 1‐alpha expression drives clear cell ovarian cancer progression.

    Published in:
    Journal of Pathology, 2025, v. 266, n. 3, p. 352, doi. 10.1002/path.6433
    By:
    • EL‐Naggar, Amal M;
    • Li, Yuqin;
    • Turgu, Busra;
    • Ding, Yuchen;
    • Wei, Longyijie;
    • Chen, Shary Yuting;
    • Trigo‐Gonzalez, Genny;
    • Kalantari, Forouh;
    • Vallejos, Rodrigo;
    • Lynch, Branden;
    • Senz, Janine;
    • Lum, Amy;
    • Douglas, J Maxwell;
    • Salamanca, Clara;
    • Thornton, Shelby;
    • Qin, Yimei;
    • Parmar, Kiran;
    • Spencer, Sandra E;
    • Leung, Samuel;
    • Woo, Michelle M M
    Publication type:
    Article
    5
    6

    Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.

    Published in:
    Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06697-8
    By:
    • Jiang, Zhixiong;
    • Yang, Yating;
    • Zhou, Jinchi;
    • Li, Xin;
    • Meng, Qingqing;
    • Yu, Xiangyi;
    • Xue, Yaxin;
    • Li, Mengyu;
    • Cai, Yichen;
    • Han, Pengchun;
    • Jiang, Mingjun;
    • Wang, Huizhen;
    • Liu, Congrong;
    • Zhao, Jing;
    • Wan, Lixin;
    • Bao, Dengke
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.

    Published in:
    Journal of Neuro-Oncology, 2025, v. 173, n. 3, p. 751, doi. 10.1007/s11060-025-05020-1
    By:
    • Nakhate, Vihang;
    • Ly, Ina;
    • Muzikansky, Alona;
    • Rapalino, Otto;
    • Allen, Jeffrey C.;
    • Blakeley, Jaishri O.;
    • Campian, Jian L.;
    • Clapp, D. Wade;
    • Dhall, Girish;
    • Jain, Rakesh K.;
    • Karajannis, Matthias A.;
    • Packer, Roger J.;
    • Tonsgard, James;
    • Ullrich, Nicole J.;
    • Korf, Bruce R.;
    • Fisher, Michael J.;
    • Plotkin, Scott R.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    TNFR2 Expression in Sporadic Young-onset CRC: An Institutional Experience.

    Published in:
    Malaysian Journal of Medicine & Health Sciences, 2025, v. 21, n. 3, p. 389, doi. 10.47836/mjmhs.21.3.45
    By:
    • Mohd Salim, Nurul Hakimah;
    • Wan Abdul Rahman, Wan Faiziah;
    • Nafi, Siti Norasikin Mohd;
    • Zakaria, Andee Dzulkarnaen;
    • Mohamud, Rohimah;
    • Sulong, Sarina;
    • Che Jalil, Nur Asyilla
    Publication type:
    Article
    30
    31
    32
    33
    34

    Development and validation of a transcription factor regulatory network‐based signature for individualized prognostic risk in lung adenocarcinoma.

    Published in:
    International Journal of Cancer, 2025, v. 156, n. 12, p. 2440, doi. 10.1002/ijc.35375
    By:
    • Wang, Kai;
    • Xiang, Jun;
    • Zhou, Jun;
    • Chen, Congcong;
    • Wang, Zhoufeng;
    • Qin, Na;
    • Zhu, Meng;
    • Bi, Lingfeng;
    • Gong, Linnan;
    • Yang, Liu;
    • Chen, Yingjia;
    • Xu, Xianfeng;
    • Dai, Juncheng;
    • Ma, Hongxia;
    • Hu, Zhibin;
    • Li, Weimin;
    • Wang, Cheng;
    • Jin, Guangfu;
    • Shen, Hongbing
    Publication type:
    Article
    35
    36

    LMP7-Specific Inhibitor M3258 Modulates the Tumor Microenvironment of Triple-Negative Breast Cancer and Inflammatory Breast Cancer.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1887, doi. 10.3390/cancers17111887
    By:
    • Xie, Xuemei;
    • Lee, Jangsoon;
    • Manyam, Ganiraju C.;
    • Pearson, Troy;
    • Walter-Bausch, Gina;
    • Friese-Hamim, Manja;
    • Zhao, Sheng;
    • Jabs, Julia;
    • Manginelli, Angela A.;
    • Piske, Nadine;
    • Mrowiec, Thomas;
    • Wolf, Corinna M.;
    • Kuntal, Bharat S.;
    • Tripathy, Debu;
    • Wang, Jing;
    • Sanderson, Michael P.;
    • Ueno, Naoto T.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1744, doi. 10.3390/cancers17111744
    By:
    • Lema, Laura;
    • Pérez-García, José Manuel;
    • Blanch, Salvador;
    • Balmaña, Judith;
    • García-Sáenz, José Ángel;
    • Vegas, Elena Filipovich;
    • Jiménez, Begoña;
    • de la Haba, Juan;
    • Campolier, Marta;
    • Shimizu, Eileen;
    • Alcalá-López, Daniel;
    • Sampayo-Cordero, Miguel;
    • Cortés, Javier;
    • Llombart-Cussac, Antonio
    Publication type:
    Article
    46
    47
    48
    49
    50